Skip to main content
. Author manuscript; available in PMC: 2016 Feb 3.
Published in final edited form as: Circulation. 2015 Feb 3;131(5):503–512. doi: 10.1161/CIRCULATIONAHA.114.001382

Figure 2.

Figure 2

Maintenance Immunosuppressant Use in Pediatric Heart Transplantation. Maintenance immunosuppression at 1 year (black bars) and 5 year (white bars) follow up in pediatric heart transplant recipients with visits from 2007 onwards. Percent of all patients receiving each drug is plotted on the Y axis. Sum across medications is greater than 100% due to concomitant use of two or more medications. MMF – mycophenolate mofetil; MPA – mycophenolic acid; mTOR – mammalian target of rapamycin. Based on published data.9